Wiesbaden, Germany

Raymond Oekonomopulos

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond Oekonomopulos. Retrieved from https://idiyas.com/inventor/raymond-oekonomopulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raymond Oekonomopulos: Innovator in Pharmaceuticals

Introduction

Raymond Oekonomopulos is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzothiazinone derivatives. His research has implications for both calcium regulation and blood glucose management.

Latest Patents

Oekonomopulos holds a patent for "Benzothiazinone derivatives, and pharmaceuticals containing them." This patent describes compounds with various functional groups that exhibit properties as excellent calcium agonists or antagonists. The compounds also play a role in regulating blood glucose levels, showcasing their potential therapeutic applications.

Career Highlights

Raymond Oekonomopulos is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has led to advancements in drug development, particularly in the area of calcium regulation and glucose management.

Collaborations

Oekonomopulos has collaborated with notable colleagues, including Rainer Henning and Ulrich Lerch. These partnerships have contributed to the success of his research and the development of innovative pharmaceutical solutions.

Conclusion

Raymond Oekonomopulos is a distinguished inventor whose work in pharmaceuticals has the potential to impact health and medicine significantly. His contributions to the field exemplify the importance of innovation in addressing complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…